Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CHD5 encodes a member of the chromodomain helicase DNA-binding protein family. Additionally we are shipping CHD5 Kits (15) and many more products for this protein.
Showing 10 out of 25 products:
Human Polyclonal CHD5 Primary Antibody for ELISA, WB - ABIN190809
Thompson, Gotoh, Kok, White, Brodeur: CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. in Oncogene 2003
CHD5 (show WRB Antibodies) methylation of rectal cancer has a great effect in influencing its clinical and pathological features.
Study shows that CHD5 (show WRB Antibodies) is a Nucleosome remodeling and deacetylase complex-associated transcriptional repressor and identifies WEE1 (show WEE1 Antibodies) as one of the CHD5 (show WRB Antibodies)-regulated genes that may link CHD5 (show WRB Antibodies) to tumor suppression.
Low CHD5 (show WRB Antibodies) expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.
CHD5 (show WRB Antibodies) is a potential tumour suppressor gene epigenetically silenced in hepatocellular carcinoma.
The tumor suppressor chromodomain helicase DNA-binding protein 5 (CHD5) remodels nucleosomes by unwrapping.
repression of CHD5 (show WRB Antibodies) gene expression in human leukemia is mediated in part by DNA methylation (show HELLS Antibodies) of its promoter.
CHD5 (show WRB Antibodies) activity is regulated by DNA methylation (show HELLS Antibodies) and repressive histone modifications. CHD5 (show WRB Antibodies) likely acts as a tumor-suppressor gene in early colorectal carcinogenesis.
CHD5 (show WRB Antibodies) might act as a tumor suppressor in glioma
These findings provide insights into the regulatory role of CHD5 (show WRB Antibodies) during neurogenesis and suggest how inactivation of this candidate tumor suppressor might contribute to neuroblastoma (show ARHGEF16 Antibodies).
Decreased expression of chromodomain helicase DNA-binding protein 5 is associated with primary gallbladder carcinoma
Chd5 (show WRB Antibodies) is a multi-faceted mediator of histone-to-protamine replacement and is important in the cascade of molecular events underlying this process of extensive chromatin remodelling.
Our data indicate that CHD5 (show WRB Antibodies) is required for normal spermiogenesis, especially for spermatid chromatin condensation.
Chd5 (show WRB Antibodies) expression is retained at high levels in differentiated neurons of the adult mouse.
Chd5 (show WRB Antibodies) binds the unmodified N terminus of H3 through its tandem plant homeodomains (PHDs).
CHD5 (show WRB Antibodies) regulates expression of neuronal genes, cell cycle genes and remodeling genes, and is linked to regulation of genes implicated in aging and Alzheimer's disease.
the association of between miR (show MLXIP Antibodies)-211-regulated CHD5 (show WRB Antibodies) expression and CHD5 (show WRB Antibodies) function in colorectal tumorigenesis
This gene encodes a member of the chromodomain helicase DNA-binding protein family. Members of this family are characterized by a chromodomain, a helicase ATP-binding domain and an additional functional domain. This gene encodes a neuron-specific protein that may function in chromatin remodeling and gene transcription. This gene is a potential tumor suppressor gene that may play a role in the development of neuroblastoma.
chromodomain helicase DNA binding protein 5
, Coronary heart disease, susceptibility to, 5
, chromodomain-helicase-DNA-binding protein 5-like
, ATP-dependent helicase CHD5
, chromodomain-helicase-DNA-binding protein 5